Business
Cochlear posts $238m loss as COVID, patent case bites – Sydney Morning Herald
Underlying profit at the hearing implant maker slid 42 per cent as coronavirus shutdowns impacted sales.
The expense brought the company’s overall net loss to $238.3 million, a 186 per cent drop on last year’s $276.7 million profit.
Cochlear shares rose 6.5 per cent to $211.28 in morning trade.
Chief executive Dig Howitt said the tough coronavirus conditions had not changed the company’s broader goals of retaining and growing market leadership for its products.
He said elective surgeries had started to flow back in key markets but Cochlear was watching closely to evaluate the impact of the pande…
-
Noosa News24 hours agoAdvocates highlight sexual violence against older people, with Queensland elder abuse inquiry underway
-
Business23 hours ago3 steps to take to build a $1,000 monthly passive income
-
Noosa News16 hours agoRallies under way as nationwide support for Palestine surges
-
Business24 hours ago3 unstoppable ASX ETFs to buy and hold for 10 years